Antiosteoporosis Effects, Pharmacokinetics, and Drug Delivery Systems of Icaritin: Advances and Prospects
Osteoporosis is a systemic skeletal disorder affecting over 200 million people worldwide and contributes dramatically to global healthcare costs. Available anti-osteoporotic drug treatments including hormone replacement therapy, anabolic agents, and bisphosphonates often cause adverse events which l...
Saved in:
Main Authors: | Lifang Gao (Author), Shuang-Qing Zhang (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A comparative study on the in vitro and in vivo antitumor efficacy of icaritin and hydrous icaritin nanorods
by: Haowen Li, et al.
Published: (2020) -
An icaritin-loaded microemulsion based on coix oil for improved pharmacokinetics and enhanced antitumor efficacy
by: Huating Zeng, et al.
Published: (2022) -
Investigating the effect of Icaritin on hepatocellular carcinoma based on network pharmacology
by: Zhong Xue, et al.
Published: (2023) -
Antiosteoporosis effect of tanshinol in osteoporosis animal models: A systematic review and meta-analysis
by: Shen Wang, et al.
Published: (2022) -
The Ginsenoside Exhibits Antiosteoporosis Effects in Ketogenic-Diet-Induced Osteoporosis via Rebalancing Bone Turnover
by: Qi Liu, et al.
Published: (2021)